Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease

被引:0
作者
Lapucci, Caterina [1 ]
Boccia, Vincenzo Daniele [2 ]
Clementi, Thoma Dario [2 ]
Schiavi, Simona [2 ]
Benedetti, Luana [1 ]
Uccelli, Antonio [1 ,2 ]
Novi, Giovanni [1 ]
Cellerino, Maria [2 ]
Inglese, Matilde [1 ,2 ]
机构
[1] IRCCS Osped Policlin San Martino, Largo Daneo 3, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy
关键词
neuromyelitis optica spectrum disorder; myelin oligodendrocyte glycoprotein antibody-associated disease; MRI; diffusion; microstructure;
D O I
10.1111/jon.13218
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) diagnosis are based on the presence of serological and magnetic resonance imaging (MRI) biomarkers. Diffusion tensor imaging (DTI), neurites orientation dispersion and density imaging (NODDI), and the Spherical Mean Technique (SMT) may be helpful to provide a microstructural characterization of the different types of white matter lesions and give an insight about their different pathological mechanisms. The aim of the study was to characterize microstructural differences between brain typical lesions (TLs) and nontypical lesions (nTLs). Methods A total of 17 NMOSD and MOGAD patients [9 Aquaporin4 (AQP4) + NMO, 2 seronegative-NMO, 6 MOGAD] underwent MRI scans on a 3 Tesla MAGNETON PRISMA. Diffusion parameters (fractional anisotropy; mean diffusivity [MD]; intracellular volume fraction [ICVF]; extra-neurite transverse diffusivity; and extra-neurite MD; neurite signal fraction) were obtained using DTI, NODDI, and SMT. Microstructural parameters within lesions were compared through a generalized linear model using age, sex, and total lesion volume as covariates. Results In NMOSD/MOGAD whole cohort (total lesions = 477), TLs showed increased MD and decreased ICVF compared to nTLs (p < .05), indicating higher inflammation and axonal loss. Similar results were found also in the AQP4 + NMO subgroup (decreased ICVF, p < .05). Furthermore, in NMOSD/MOGAD whole cohort and in AQP4 + NMO subgroup, TLs showed a trend toward higher EXRATRANS than nTLs, suggesting a more severe degree of demyelination within TLs. Conclusions TLs and nTLs in NMOSD/MOGAD showed different diffusion MRI-derived microstructural features, with TLs showing a more severe degree of inflammation and fiber disruption with respect to nTLs.
引用
收藏
页码:459 / 465
页数:7
相关论文
共 50 条
[31]   Altered Microstructure of Cerebral Gray Matter in Neuromyelitis Optica Spectrum Disorder-Optic Neuritis: A DKI Study [J].
Zhang, Hanjuan ;
Li, Qing ;
Liu, Lei ;
Qu, Xiaoxia ;
Wang, Qian ;
Yang, Bingbing ;
Xian, Junfang .
FRONTIERS IN NEUROSCIENCE, 2021, 15
[32]   The role of imaging in diagnosing neuromyelitis optica spectrum disorder [J].
Matthews, Lucy A. ;
Palace, Jacqueline A. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (03) :284-293
[33]   Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients [J].
Taha, Sara I. ;
Bakr, Salwa I. ;
Fouad, Nermeen T. ;
Zamzam, Dina ;
Mohamed, Yasmine A. .
SCIENTIFIC REPORTS, 2025, 15 (01)
[34]   Factors associated with disease relapse rate in the Neuromyelitis optica spectrum disorder [J].
Li, Hai-yun ;
Cui, Cai-san ;
Yang, Hui-min ;
Jiang, Wen-jing ;
Yang, Xiang-dong .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (10) :1114-1119
[35]   Satralizumab in the treatment of neuromyelitis optica spectrum disorder [J].
Duchow, Ankelien ;
Bellmann-Strobl, Judith .
NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (01) :49-59
[36]   Frequency of comorbidities in Neuromyelitis Optica spectrum disorder [J].
Barzegar, Mahdi ;
Mirmosayyeb, Omid ;
Nehzat, Nasim ;
Vaheb, Saeed ;
Shaygannejad, Vahid ;
Asgari, Nasrin .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
[37]   Hemifacial anhidrosis in neuromyelitis optica spectrum disorder [J].
Miyaue, Noriyuki ;
Yabe, Hayato .
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (02) :107-108
[38]   Urinalysis in patients with neuromyelitis optica spectrum disorder [J].
Chen, Z. G. ;
Huang, J. ;
Fan, R. ;
Weng, R. H. ;
Shinohara, R. T. ;
Landis, J. R. ;
Chen, Y. ;
Jiang, Y. .
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (04) :619-625
[39]   Neuromyelitis Optica Spectrum Disorder: A Case Report [J].
Yaregal, Samson ;
Bekele, Nebiyu ;
Gebrewold, Yonathan ;
Tadesse, Abilo .
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 :643-648
[40]   Quality of life in patients with myelin oligodendrocyte glycoprotein antibody associated disease compared to patients with AQP4-IgG positive neuromyelitis optica spectrum disorders: A Korean multicenter study [J].
Lyou, Hyun Ji ;
Shin, Ha Young ;
Lee, Hye Lim ;
Kwon, Young Nam ;
Oh, Seong-il ;
Oh, Jeeyoung ;
Cho, Eun Bin ;
Kim, Sunyoung ;
Baek, Seol-Hee ;
Kim, Byung-Jo ;
Sohn, Eunhee ;
Seok, Jin Myoung ;
Min, Ju-Hong ;
Kim, Seung Woo ;
Kim, Byoung Joon .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91